Genoa Pharmaceuticals Competitors and Similar CompaniesClear all
Genoa Pharmaceuticals's competitors and similar companies include GBT (Global Blood Therapeutics), JCR Pharmaceuticals, Heron Therapeutics and Sosei Heptares.
 Genoa Pharmaceuticals Genoa Pharmaceuticals develops therapies for the treatment of idiopathic pulmonary fibrosis. |  GBT (Global Blood Therapeutics) GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. |  JCR Pharmaceuticals JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products. |  Heron Therapeutics Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development. | ||
Founding Date | Founding Date 2011 | Founding Date 2012 | Founding Date 1975 | Founding Date 1983 | Founding Date 1990 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Seattle, US HQ | Locations South San Francisco, US HQ Paris, FR Berlin, DE Baar, CH London, GB | Locations Ashiya, JP HQ Kobe, JP Kobe, JP Kobe, JP Kobe, JP | Locations San Diego, US HQ | Locations Tokyo, JP HQ Dublin, IE Cambridge, GB London, GB |
Employees | Employees 1 | Employees 352106% increase | Employees 934 | Employees 20333% decrease | Employees 387 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 4.4 b | Valuation ($) 533.9 m | Valuation ($) 268.5 m | Valuation ($) 697 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $194.7m (FY, 2021) | Revenue (est.) ¥33.1b (FY, 2025) | Revenue (est.) $154.9m (FY, 2025) | Revenue (est.) ¥29.6b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $3.3m (FY, 2021) | Cost of goods ¥8b (FY, 2025) | Cost of goods $41.3m (FY, 2025) | Cost of goods ¥7.3b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ¥25.1b (FY, 2025) | Gross profit $113.6m (FY, 2025) | Gross profit ¥24b (FY, 2025) |
Net income | Net income N/A | Net income ($303.1m) (FY, 2021) | Net income (¥4.7b) (FY, 2025) | Net income ($20.2m) (FY, 2025) | Net income (¥12.5b) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 64.2m | Total funding raised $ 88.7m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 65m |
For sources of this data, please see the company profile
View Company Profiles
GBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
352
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
View companyJCR Pharmaceuticals
HQ
Ashiya, JP
Employees
934
JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products.
View companyHeron Therapeutics
HQ
San Diego, US
Employees
203↓ 33% decrease
Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development.
View company
Sosei Heptares
HQ
Tokyo, JP
Employees
387
Sosei Heptares is a biopharmaceutical company that specializes in drug development.
View company